Last reviewed · How we verify

Ketamine and Prolonged Exposure in PTSD

NCT03960658 PHASE1, PHASE2 COMPLETED Results posted

This study aims at investigating the effectiveness of the drug, Ketamine, in combination with Prolonged Exposure (PE) therapy for people suffering from PTSD. Participation in the study includes Ketamine infusions, which occur once a week for three weeks. PE therapy sessions will be scheduled one day after each infusion, and may continue up to 12 weeks. After completely therapy, there will be two monthly follow-up assessment visits.

Details

Lead sponsorMinneapolis Veterans Affairs Medical Center
PhasePHASE1, PHASE2
StatusCOMPLETED
Enrolment12
Start dateWed Apr 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionWed Dec 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United States